Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blind Placebo-Controlled Trial Of The Effects Of Docosahexaenoic Acid (DHA) In Slowing The Progression Of Alzheimer's Disease

NCT00440050 is registered in ClinicalTrials.gov with Alzheimer's Disease Cooperative Study (ADCS) as lead sponsor.

NCT NCT00440050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blind Placebo-Controlled Trial Of The Effects Of Docosahexaenoic Acid (DHA) In Slowing The Progression Of Alzheimer's Disease
Lead sponsor
Alzheimer's Disease Cooperative Study (ADCS)
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
May 31, 2009
Enrollment
402 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease